Skip to main content
SAGE Open Medicine logoLink to SAGE Open Medicine
. 2021 Sep 28;9:20503121211048748. doi: 10.1177/20503121211048748

Alcohol use disorder and its determinant factors among patients with schizophrenia attending treatment at mental specialized hospital, Addis Ababa, Ethiopia: A cross-sectional study

Habtamu Tadesse 1, Yohannes Mirkana 2, Tadesse Misgana 1,
PMCID: PMC8481719  PMID: 34603729

Abstract

Background:

Alcohol use disorder is one of the primary causes of avoidable death, illness, and injury in many societies throughout the world. Although alcohol use disorder can influence the natural history of a disease, disease recurrence, quality of life, and treatment adherence in psychiatric patients, the data on its magnitude is scarce.

Objectives:

This study was aimed to determine the magnitude of alcohol use disorder and its determinants among patients with schizophrenia attending a mental specialized hospital in Addis Ababa, Ethiopia.

Methods:

An institutional-based cross-sectional study was conducted from May 15 to June 15, 2018. An alcohol use disorder identification test was employed among a sample of 414 randomly selected patients with schizophrenia. Alcohol use disorder was categorized as hazardous drinking (Alcohol Use Disorders Identification Test (AUDIT) score of 8–15), harmful drinking (AUDIT score of 16–19), and alcohol dependence (AUDIT score of 20 or above). The data were entered into Epi-Data 3.1 and exported to SPSS 20 for analysis. Logistic regression was fitted to identify factors associated with alcohol use disorder.

Results:

The prevalence of alcohol use disorder was 38.4% (95% confidence interval (CI) 33.7, 42.9). Of this, 22.4% of the patients had hazardous drinking, 8.4% harmful drinking, and 7.6% alcohol dependence. Factors associated with alcohol use disorder were male sex (adjusted odds ratio (AOR) = 5.8, 95% CI 2.55, 13.19), being single (AOR = 3.0, 95% CI 1.63, 5.51), divorced (AOR = 4.3, 95% CI 1.95, 9.47) and widowed (AOR = 3.5, 95% CI 1.39, 8.81), having family history of alcoholism (AOR = 3.8, 95% CI 1.98, 7.19), longer duration of illness (AOR = 3.9, 95% CI 1.83, 8.36), previous history of psychiatric diagnosis (AOR = 2.2, 95% CI 1.1, 4.34), and concomitant use of non-alcoholic substances (AOR = 3.7, 95% CI 2.06, 6.74).

Conclusions:

Almost four in ten patients with schizophrenia had alcohol use disorder. Male sex, single, divorced, and widowed, family history of alcohol use, long duration of illness, previous history of psychiatric diagnosis, and concomitant use of non-alcoholic substances were significantly associated with alcohol use disorder. Continuous counseling of at risk populations about alcohol consumption should be strengthened.

Keywords: Alcohol use disorder, associated factors, schizophrenia, prevalence, Ethiopia

Introduction

Alcohol is a psychoactive substance with dependence-producing properties that has been extensively used in many cultures for centuries. Harmful use of alcohol leads to a widespread health problem as well as socio-economic burdens in societies.13 Alcohol ranks among the top 10 risk factor causes of disability-adjusted life years (DALYs) lost, both internationally and in all three income categories of countries. It has been estimated that 4.4% of DALYs lost are due to alcohol.4

Alcohol use disorder (AUD) is a major cause or increases the risk for many health-related problems and complicates their treatment.5 It has a major impact on public health and is a contributory factor for about 60 categories of diseases and injuries68 and 2.9 million deaths globally.9 AUD is common in the general population, the risk is 2 times higher among psychiatric patients.10 Such co-morbid conditions prolong the duration of the psychiatric disorder, higher rates of homelessness, increase the frequency of admissions, and lead to lower quality of life and social complications.1113

Almost half of the schizophrenic patients have a co-morbid substance use disorder during their lifetime.14 Many studies done throughout the 20 years show an increase of co-morbidity of disorders caused by harmful use or abuse of alcohol and other psychoactive substances in the population of schizophrenia.15,16 An additional diagnosis of AUD can affect the natural history of a disease, disease recurrence, patient quality of life, and treatment compliance in patients with schizophrenia. Higher proportions of drinkers had a longer duration of schizophrenic illness and longer in-patients stay on a mental health ward.1719

Since AUDs can negatively affect compliance to treatment, effectiveness of medications, and increases the rate of hospitalization, there is a huge necessitate for screening and diagnosing co-morbid AUDs among patients with psychiatric disorders.20,21 Most patients in low and middle-income countries with severe psychiatric disorders do not get management for their mental illness including for their concurrent drug addiction in general.2224 Therefore, early identification of AUD can be useful to prevent several complications, as well as an intervention opportunity to propose an integrated treatment to dual diagnosis patients.

Although a variety of traditional and modern alcoholic drinks are recognized to be used extensively in Ethiopia, to the level of our knowledge very limited studies have been conducted to determine the prevalence of AUD among patients with mental illnesses. So, this study was conducted to assess the magnitude of AUD and its associated factors among patients with schizophrenia attending care at a specialized mental hospital in Ethiopia.

Material and methods

Study setting and period

The study was conducted in Amanuel Mental Specialized Hospital (AMSH) located in Addis Ababa, the capital of Ethiopia. It is the only specialized mental hospital giving the service for patients with psychiatric disorders coming from the whole countryside. Of 61,580 patients who received treatment in 2017, 16,615 were related with schizophrenia. On average, about 2700 outpatients with schizophrenia get follow-up services each month. The study was conducted from 15 May to 15 June 2018.

Study design and population

A cross-sectional study was conducted. The source population included patients with schizophrenia on follow-up treatment at AMSH while the study adult population included patients who were diagnosed as per the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) or 5th Edition (DSM-5) criteria, and on follow-up at hospital during the study period.

Inclusion criteria

Participants age 18 years and above were included in the study.

Exclusion criteria

Patients who were severely ill and not capable to give required information were excluded from the study.

Sample size determination and sampling technique

The sample size was estimated using single population proportion formula with 95% confidence interval (CI), 5% marginal error, 10% non-response rate, and the proportion of AUD of 42.7% (prevalence taken from a study conducted at Jimma, southwestern Ethiopia).25 Finally, the estimated sample size is 414. Using systematic random sampling technique, every other patient was included in the study after the first one was selected randomly.

Study variables

  • Dependent variables: Alcohol use disorder.

  • Independent variables:

  • • Socio-demographic factors: age, sex, marital status, educational status, residence, and occupation.

  • • Clinical factors: duration of illness, chronic medical illness, and previous history of a psychiatric diagnosis other than schizophrenia.

  • • Other substance use: Khat, Nicotine, and others.

Operational definitions

  • Alcohol use disorder: “A total Alcohol Use Disorders Identification Test (AUDIT) score of eight or more was used to define probable ‘alcohol use disorder.’ A total AUDIT score of 1–7 indicated social drinking, a score of 8–15 indicated ‘hazardous drinking,’ a score of 16–19 indicated ‘harmful drinking,’ and a score of 20 or above indicated probable alcohol dependence.”26

  • Chronic medical illness: additional co-morbid chronic medical illness with schizophrenia.

  • Previous history of psychiatric diagnosis: having a previous history of mental illness other than schizophrenia.

  • Concomitant Substance use: those who use any substance (khat, tobacco, and others) other than alcohol.

Data collection tools and procedure

The Alcohol Use Disorders Identification Test (AUDIT) was used to collect data. AUDIT is a 10-item alcohol screening instrument and emphasizes the identification of AUD in the last 12 months. AUDIT, developed by the World Health Organization, has been found to be effective in identifying people with a drinking problem such as hazardous drinking, harmful drinking, and alcohol dependence.26 The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) (V.3.1) was used to assess the substance use of the respondents other than alcohol.27 Clinical characteristics were obtained from yes/no answers of respondents and patients’ medical records.

Data were collected by five trained psychiatric nurses. Data collectors and supervisors were trained for 2 days on the purpose of the study, details of the questionnaire, interviewing techniques, the importance of the privacy, and ensuring the patients’ confidentiality.

Data quality control

Data were collected using a standardized questionnaire which was translated into the local language (Amharic) and back to English by individuals with good command of English. The questionnaire was pretested on 5% of the sample size on schizophrenic patients in St. Paul’s Hospital Millennium Medical College.

Data processing and analysis

The data were processed using Epidata version 3.1 and analyzed using SPSS version 20. Findings were described using percentages and frequencies. Bivariable and multivariable logistic regression was fitted to identify factors associated with AUD. Association was described using odds ratio (OR) along with its 95% CI.28 Variables with p-value < 0.25 in the bivariable logistic regression were entered into the multivariable logistic regression. Finally, variables with p-value < 0.05 in the multivariable logistic regression were considered as significantly associated with AUD.

Ethical considerations

Ethical clearance was obtained from the Ethical Review Committee (ERC) of AMSH (Ref NO: Am/146/4/214). Before the questionnaire was administered, informed voluntary written consent was obtained from each study participant. Confidentiality was maintained at all levels of the study through collecting anonymous data. Patients with AUD were linked to substance-related specialist.

Results

Socio-demographic description

Among 414 psychiatric outpatients enrolled in the study, 406 consented to participate, resulting in a response rate of 98%. The mean age of the respondent was 36.6 (± 10.2 SD) years. Majority of the respondents were males (77.3%), live in urban areas (76.1%), and unemployed (67.5%). Close to four in ten (38.2%) respondents attended secondary school (Table 1).

Table 1.

Description of socio-demographic characteristic of respondents at AMSH, Addis Ababa, Ethiopia, 2018.

Variables Category Frequency (n = 406) Percentage
Age 18–29 106 26.0
30–44 170 42.0
⩾45 130 32.0
Mean age/SD 36.6/±10.2
Sex Male 314 77.3
Female 92 27.7
Religion Orthodox 259 63.8
Muslim 78 19.2
Protestant 50 12.3
Other religion 19 4.7
Marital status Married 183 45.0
Single 134 33
Divorced 55 13.5
Widowed 34 8.5
Ethnicity Oromo 140 34.5
Amhara 138 34.0
Gurage 86 21.2
Other ethnicity 42 10.3
Education Illiterate 55 13.5
Primary 109 26.8
Secondary 155 38,2
College and above 87 21.4
Residence Urban 309 76.1
Rural 97 23.9
Occupation status Employed 274 67.5
Unemployed 132 32.5
Living arrangement with partner/ family 354 87.2
Alone 52 12.8
Income ⩽1000 158 38.9
1001–1600 76 18.7
⩾1601 172 42.2

AMSH: Amanuel Mental Specialized Hospital; SD: standard deviation; other religion: Catholic, Wakefata; other ethnicity: Wolayta, Silte, Tigre.

Clinical characteristics of the study participants

Half of the respondents (50.0%) had above 5 years duration of illness and 40.6% were using non-alcoholic substances. About 7.6% of the patients had additional medical illnesses, of those hypertension was the most common (3.9%) followed by diabetes mellitus (2.5%). A total of 71.7% participants reported family history of alcohol use and 20.7% had previous history of a psychiatric diagnosis other than schizophrenia (major depressive disorder (9.6%) and bipolar disorder (8.4%) (Table 2).

Table 2.

Description of clinical characteristic of study participants at AMSH, Addis Ababa, Ethiopia, 2018.

Variables Category Frequency (n = 406) Percentage
Duration of illness <2 years 91 22.4
2–5 years 112 27.6
>6 years 203 50.0
Co-morbid psychiatric diagnosis Yes 84 20.7
No 322 79.3
Chronic medical illness Yes 31 7.6
No 375 92.4
Non-alcohol substance use yes 165 40.6
No 241 59.4
Type of non-alcohol substance use Cigarette 129 31.8
Khat 110 27.1
Others 16 3.94
A family history of alcohol use yes 291 71.7
No 115 28.3

AMSH: Amanuel Mental Specialized Hospital; other substance: cannabis, other traditional substance.

Prevalence of alcohol use disorder

The overall prevalence of AUD was 38.4% (95% CI 33.7, 42.9). Of this, 91 (22.4%) had hazardous drinking, 34 (8.4%) harmful drinking, and 31 (7.6%) alcohol dependence. Most of the respondents (61.6%) were social drinkers (Figure 1).

Figure 1.

Figure 1.

Alcohol use disorders among schizophrenic patients according to their degree (level) of severity at AMSH, Addis Ababa Ethiopia, 2018.

Factors associated with alcohol use disorder

In the bivariable analysis, sex, marital status, level of education, living arrangement, job, family history of alcohol use, duration of illness, previous history of a psychiatric diagnosis, co-morbid medical illness, and other non-alcoholic substance use were significantly associated with AUD. In the multivariable logistic regression, however, only gender of respondent, marital status, family history of alcohol use, duration of illness, previous history of a psychiatric diagnosis, and non-alcoholic substance remained statistically significant at p-value < 0.05.

Males were 6 times (adjusted odds ratio (AOR) = 5.8, 95% CI 2.55, 13.19) more likely to have AUD compared with females. Being single (AOR = 3.0, 95% CI 1.63, 5.51), divorced (AOR = 4.3, 95% CI 1.95, 9.47), and widowed (AOR = 3.5, 95% CI 1.39, 8.81) was also significantly associated with AUD. Patients who reported a family history of alcoholism were four times (AOR = 3.8, 95% CI 1.98, 7.19) more likely to have AUD. The odds of having AUD was 3.9 (AOR = 3.9, 95% CI 1.83, 8.36) among patients with longer duration of illness as compared with patients having the illness less than 5 years. Patients who had a previous history of a psychiatric diagnosis other than schizophrenia were more likely to have AUD (AOR = 2.2 95% CI 1.1, 4.34) as compared with patients not having a previous history of a psychiatric diagnosis other than schizophrenia. Patients who reported using non-alcoholic substances were four time (AOR = 3.7 95% CI 2.06, 6.74) to have AUD as compared with those not reported using non-alcoholic substances (Table 3).

Table 3.

Factors associated with alcohol use disorder among patients with schizophrenia at AMSH, Addis Ababa, Ethiopia may, 2018.

Variables AUD
COR (95% CI) AOR (95% CI)
Yes No
Sex
 Male 145 169 6.32 (3.24, 12.32) 5.8 (2.55, 13.19)*
 Female 11 81 1 1
Marital status
 Single 71 63 4.45 (2.71, 7.30) 3.0 (1.63, 5.51)**
 Married 37 146 1 1
 Divorced 29 26 4.4 (2.32, 8.35) 4.3 (1.95, 9.47)*
 Widowed 19 15 5 (2.32, 10.76) 3.5 (1.39, 8.81)*
Level of educational
 Unable to read and write 23 35 0.5 (0.24, 1.01) 4.0 (1.51, 10.69)
 Primary 46 60 0.7(0.39, 1.22) 5.5 (2.36, 13.07)
 Secondary 73 76 0.72 (0.42, 1.22) 3.9 (1.79, 8.67)
 Collage and above 14 79 1 1
Job
 Employed 86 188 1 1
 Unemployed 70 62 2.47 (1.61, 3.78) 1.3 (0.73, 2.36)
Living arrangement
 With family 127 227 1 1
 Alone 29 23 2.25 (1.25, 4.06) 2.1 (0.7, 4.1)
Family history of alcohol use
 Yes 132 24 3.15 (1.90, 5.22) 3.8 (1.98, 7.19)*
 No 159 91 1 1
Duration of illness
 ⩽2 years 17 74 1 1
 2–5 years 41 71 2.5 (1.31, 4.83) 2.0 (0.88, 4.62)
 ⩾6 years 98 105 4.1 (2.24, 7.36) 3.9 (1.83, 8.36)***
Co-morbid psychiatric diagnosis
 Yes 44 112 2.1 (1.27, 3.35) 2.2 (1.1, 4.34)*
 No 40 210 1 1
Medical illness
 Yes 18 138 2.38 (1.13, 5.00) 1.14 (0.45, 2.92)
 No 13 237 1 1
Non-alcoholic substance use
 Yes 97 59 4.4 (2.87, 6.74) 3.7 (2.06, 6.74)*
 No 68 182 1

AMSH: Amanuel Mental Specialized Hospital; AUD: alcohol use disorder; CI: confidence interval; COR: crude odds ratio; AOR: adjusted odds ratio; other substance: cannabis, other traditional substance.

*

Statistically significant at p-value < 0.05, **Statistically significant at p-value < 0.01, ***Statistically significant at p-value < 0.001.

Discussion

In this study, AUD and its associated factors were assessed among schizophrenic patients attending a specialized mental health hospital in Addis Ababa. We found that almost four in ten (38.4%) of schizophrenic patients had AUD. Of this, 22.4% had hazardous drinking, 8.4% had harmful drinking, and 7.6% had alcohol dependence. Most of the respondents (61.6%) were social drinkers. Factors associated with AUD were being male, single, divorced and widowed, family history of alcoholism, longer duration of illness, having previous history of a psychiatric diagnosis, and using non-alcoholic substance.

This finding is consistent with previous studies in Ethiopia, Jimma (42.7%)25 and Gondar (36.2%),29 South Africa (41.2%),30 Australia (38%),31 and Switzerland (35.1%).32 This indicates AUD is a challenge among patients with schizophrenia regardless of settings. Given the challenge of being on long term antipsychotic drug therapy, schizophrenia patients require a buddy that would support in the adherence process and/or counsel on the hazards of alcohol on their health and adherence process.

The result is, however, higher than community-based studies from Addis Ababa (2.7%)33 and Butajira (3.7%),34 Ethiopia. It is similarly higher than findings from primary care clinics in South African (17.6%),35 and population-based studies in Thailand (10.9%) and Singapore (3.6%).36,37 In addition to the difference in the study setting—a specialized mental health hospital and community based, the difference might be attributed to the difference in the identification tool vs. Cut down, Annoyed, Guilty, and Eye-opener (AUDIT vs. CAGE). Relatively, CAGE is designed to detect more severe AUDs and therefore could underreport the burden. Studies from Tanzania, Australia, and United State reported higher proportion of AUD, 59.3%,38 77.3%,39 and 57%,17 respectively. This could be explained by the difference in the study population and design.

In congruent with studies conducted in Ethiopia,25 Tanzania,38 Kenya,40 India,41 and Serbia,42 males were more likely to have AUD compared with females. Given the overall lower alcohol consumption among females, compared with males, this result was not unexpected. It was likely both psychosocial and biological etiologies lead to the greater risk of AUD in men. Males are known to engage in risky behaviors, including heavy alcohol consumption, and this is considered a male norm.43,44

Being single, divorced, and widowed was also significantly associated with AUD. This finding was consistent with studies in Nigeria,45 India,46 and Brazil.47 This could be explained by the fact that single persons were free of family control and consumed alcohol as married persons. In addition, they were able to make independent decisions throughout their lives and results in participating in alcoholic beverages. The other reason might be single in marital status had less responsibility to their family than married one and they participated in drinking than their counterparts.

Patients with family history of alcoholism were found to have AUD compared with their counterparts, a result which was reported in Jimma25 and Sweden.48 This is due to both schizophrenia and AUDs have biological/heredity effects, the overlap between alcohol use problems and other psychiatric problems could indicate similar etiological factors in the development of such problems. In line with a study reported in India, schizophrenic patients with longer duration (>6 years) were more likely to have AUD.46 Patients who had a previous history of a psychiatric diagnosis other than schizophrenia were more likely to have AUD as compared with patients not having a previous history of a psychiatric diagnosis other than schizophrenia. This might be because people with such diagnoses have highly impaired judgment and insight as well as aggressiveness and uncontrolled emotions. This was supported by a study conducted in Sweden.48

Patients who reported using substance other than alcohol (smoking and Khat) were more likely to have AUD. A similar findings were reported from Jimma,25 Serbia,42 and Sweden.48 It was widely believed that schizophrenic patients smoke to increase hepatic clearance and to restore the dopamine blockage of certain antipsychotic medications to diminish their side effects.28,49 More recently, it became obvious that cigarette smoking may also be reinforcing for patients because it improves psychiatric symptoms, most notably negative and cognitive symptoms.50,51 However, there is little support for this view, as clinical studies are lacking and the results of available studies are not conclusive. In addition, it might be due to behavioral concordance of using one type of substance with other substances, and, perhaps the illness dictates the use of multiple substances at the same time.

Limitation of the study

This study has some important limitations that should be kept in mind when interpreting the results. The cross-sectional nature of the study design does not confirm a definitive cause-and-effect relationship. Some variables like duration of illness and family history of alcohol use rely on the patient’s history that might have recalled bias which could be higher among schizophrenic patients. Social desirability bias regarding alcohol use might be introduced as the result of the face-to-face interview in the vicinity of the hospital.

Conclusions

Almost four in ten patients with schizophrenia suffer from AUD. Being male sex, single, divorced and widowed, having family history of alcohol use, long duration of illness, previous history of psychiatric diagnosis, and using non-alcoholic substance use were significantly associated with AUD. Strong screening for alcohol and counseling on its effect on schizophrenic patients should be instituted. There is a need for objective measuring system for AUD.

Supplemental Material

sj-docx-1-smo-10.1177_20503121211048748 – Supplemental material for Alcohol use disorder and its determinant factors among patients with schizophrenia attending treatment at mental specialized hospital, Addis Ababa, Ethiopia: A cross-sectional study

Supplemental material, sj-docx-1-smo-10.1177_20503121211048748 for Alcohol use disorder and its determinant factors among patients with schizophrenia attending treatment at mental specialized hospital, Addis Ababa, Ethiopia: A cross-sectional study by Habtamu Tadesse, Yohannes Mirkana and Tadesse Misgana in SAGE Open Medicine

Acknowledgments

We thank the Amanuel Mental Specialized Hospital for facilitating the research work. We also thank the data collectors, supervisors, and the study participants.

Footnotes

Author contributions: H.T. conceived and designed the study. H.T., Y.M, and T.M. adopted data collection instruments and acquisition of data. H.T., Y.M, and T.M. carried out the data management. H.T. analyzed the data and interpreted findings. T.M. drafted the manuscript with a critical revision from H.T. and Y.M. All authors read the final version and approved for submission.

Data availability: The data used to support the findings of this study are available from the corresponding author upon a reasonable request.

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical approval: Ethical approval for this study was obtained from Ethical Review Committee of Amanuel Mental Specialized Hospital (approval number: Am/14604/214).

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

Informed consent: Written informed consent was obtained from all subjects before the study.

Supplemental material: Supplemental material for this article is available online.

References

  • 1.Marsano LS, Mendez C, Hill D, et al. Diagnosis and treatment of alcoholic liver disease and its complications. Alcohol Res Health 2003; 27(3): 247–256. [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization (WHO). Global status report on alcohol and health 2014. Geneva: WHO, 2014. [Google Scholar]
  • 3.Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 2005; 352(6): 596–607. [DOI] [PubMed] [Google Scholar]
  • 4.Redmond A, Horne J, Porter J, et al. Alcohol use among adolescents and adults—New Hampshire, 1991-2003. MMWR Morb Mortal Wkly Rep 2004; 53(8): 174–174. [PubMed] [Google Scholar]
  • 5.Frances AJ, Galanter M, Kleber HD. Diagnostic and statistical manual of mental disorders: DSM-IV-TR®. Washington, DC: American Psychiatric Publishing, 2000. [Google Scholar]
  • 6.Caetano R, Cunradi C. Alcohol dependence: a public health perspective. Addiction 2002; 97(6): 633–645. [DOI] [PubMed] [Google Scholar]
  • 7.Rehm J, Gmel GE, Sr, Gmel G, et al. The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction 2017; 112(6): 968–1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005; 365(9458): 519–530. [DOI] [PubMed] [Google Scholar]
  • 9.Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2224–2260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264(19): 2511–2518. [PubMed] [Google Scholar]
  • 11.Farren CK, Murphy P, McElroy S. A 5-year follow-up of depressed and bipolar patients with alcohol use disorder in an Irish population. Alcohol Clin Exp Res 2014; 38(4): 1049–1058. [DOI] [PubMed] [Google Scholar]
  • 12.Marten R, Hawkins B. Stop the toasts: the Global Fund’s disturbing new partnership. Lancet 2018; 391(10122): 735–736. [DOI] [PubMed] [Google Scholar]
  • 13.McArdle P, Wiegersma A, Gilvarry E, et al. European adolescent substance use: the roles of family structure, function and gender. Addiction 2002; 97(3): 329–336. [DOI] [PubMed] [Google Scholar]
  • 14.Kavanagh DJ, Trembath M, Shockley N, et al. The DrugCheck Problem List: a new screen for substance use disorders in people with psychosis. Addict Behav 2011; 36(9): 927–932. [DOI] [PubMed] [Google Scholar]
  • 15.Schlauch RC, Levitt A, Bradizza CM, et al. Alcohol craving in patients diagnosed with a severe mental illness and alcohol use disorder: bidirectional relationships between approach and avoidance inclinations and drinking. J Consult Clin Psychol 2013; 81(6): 1087–1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Xie H, Drake RE, McHugo GJ, et al. The 10-year course of remission, abstinence, and recovery in dual diagnosis. J Subst Abuse Treat 2010; 39(2): 132–140. [DOI] [PubMed] [Google Scholar]
  • 17.Drake RE, Luciano AE, Mueser KT, et al. Longitudinal course of clients with co-occurring schizophrenia-spectrum and substance use disorders in urban mental health centers: a 7-year prospective study. Schizophr Bull 2016; 42(1): 202–211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hunt GE, Large MM, Cleary M, et al. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: systematic review and meta-analysis. Drug Alcohol Depend 2018; 191: 234–258. [DOI] [PubMed] [Google Scholar]
  • 19.Montross LP, Barrio C, Yamada A-M, et al. Tri-ethnic variations of co-morbid substance and alcohol use disorders in schizophrenia. Schizophr Res 2005; 79(2–3): 297–305. [DOI] [PubMed] [Google Scholar]
  • 20.Burger M, Mensink G, Brönstrup A, et al. Alcohol consumption and its relation to cardiovascular risk factors in Germany. Eur J Clin Nutr 2004; 58(4): 605–614. [DOI] [PubMed] [Google Scholar]
  • 21.Cuffel BJ, Heithoff KA, Lawson W. Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Community Psychiatry 1993; 44(3): 247–251. [DOI] [PubMed] [Google Scholar]
  • 22.Barnaby B, Drummond C, McCloud A, et al. Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. BMJ 2003; 327(7418): 783–784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Jones-Webb R, Jacobs DR, Jr, Flack JM, et al. Relationships between depressive symptoms, anxiety, alcohol consumption, and blood pressure: results from the CARDIA study. Alcohol Clin Exp Res 1996; 20(3): 420–427. [DOI] [PubMed] [Google Scholar]
  • 24.McCloud A, Barnaby B, Omu N, et al. Relationship between alcohol use disorders and suicidality in a psychiatric population: in-patient prevalence study. Br J Psychiatry 2004; 184: 439–445. [DOI] [PubMed] [Google Scholar]
  • 25.Zenebe Y, Negash A, Feyissa G, et al. Alcohol use disorders and its associated factors among psychiatric Outpatients in Jimma University Specialized Hospital, Southwest Ethiopia. J Alcohol Drug Depend 2015; 3: 1000208. [Google Scholar]
  • 26.Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993; 88(6): 791–804. [DOI] [PubMed] [Google Scholar]
  • 27.Humeniuk R, Ali R, Babor TF, et al. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Addiction 2008; 103(6): 1039–1047. [DOI] [PubMed] [Google Scholar]
  • 28.Mallet J, Le Strat Y, Schurhoff F, et al. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort. Eur Arch Psychiatry Clin Neurosci 2019; 269(4): 449–457. [DOI] [PubMed] [Google Scholar]
  • 29.Kassew T, Kiflie M, Minichil W, et al. Alcohol use disorder and its associate factors relating to patients with severe mental disorders attending psychiatric follow-ups in Northwest Ethiopia. Neuropsychiatr Dis Treat 2021; 17: 1801–1810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pengpid S, Peltzer K, Van der Heever H. Prevalence of alcohol use and associated factors in urban hospital outpatients in South Africa. Int J Environ Res Public Health 2011; 8(7): 2629–2639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Abou-Saleh MT, Janca A. The epidemiology of substance misuse and comorbid psychiatric disorders. Acta Neuropsychiatr 2004; 16(1): 3–8. [DOI] [PubMed] [Google Scholar]
  • 32.Gammeter R, Nay C, Bissery A, et al. Frequency of alcohol use disorders in patients admitted in a psychiatric hospital according to admission diagnosis. Schweiz Arch Neurol Psychiatr 2006; 157: 290–296. [Google Scholar]
  • 33.Kebede D, Alem A. The epidemiology of alcohol dependence and problem drinking in Addis Ababa, Ethiopia. Acta Psychiatr Scand Suppl 1999; 397: 30–34. [DOI] [PubMed] [Google Scholar]
  • 34.Alem A, Kebede D, Kullgren G. The epidemiology of problem drinking in Butajira, Ethiopia. Acta Psychiatr Scand Suppl 1999; 397: 77–83. [DOI] [PubMed] [Google Scholar]
  • 35.Ward CL, Mertens JR, Flisher AJ, et al. Prevalence and correlates of substance use among South African primary care clinic patients. Subst Use Misuse 2008; 43(10): 1395–1410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Junsirimongkol B, Khamwongpin M, Kongsuk T, et al. The prevalence of alcohol use disorders and psychiatric comorbidity in Thailand: national epidemiological survey 2008. J Ment Health Thai 2011; 19(2), https://he01.tci-thaijo.org/index.php/jmht/article/view/979 [Google Scholar]
  • 37.Subramaniam M, Abdin E, Vaingankar J, et al. Prevalence and correlates of alcohol use disorders in the Singapore Mental Health Survey. Addiction 2012; 107(8): 1443–1452. [DOI] [PubMed] [Google Scholar]
  • 38.Hauli KA, Ndetei DM, Jande MB, et al. The prevalence of substance use among psychiatric patients: the case study of Bugando Medical Centre, Mwanza (Northern Tanzania). Subst Abus 2011; 32(4): 238–241. [DOI] [PubMed] [Google Scholar]
  • 39.Fowler IL, Carr VJ, Carter NT, et al. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24(3): 443–455. [DOI] [PubMed] [Google Scholar]
  • 40.Kuria MW, Ndetei DM, Obot IS, et al. The association between alcohol dependence and depression before and after treatment for alcohol dependence. ISRN Psychiatry 2012; 2012: 482802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.United Nations Office on Drugs and Crime. World drug report 2010. United Nations, 2010, https://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html
  • 42.Leposavić L, Dimitrijević D, Đorđević S, et al. Comorbidity of harmful use of alcohol in population of schizophrenic patients. Psychiatr Danub 2015; 27(1): 84–89. [PubMed] [Google Scholar]
  • 43.Getachew T, Defar A, Teklie H, et al. Magnitude and predictors of excessive alcohol use in Ethiopia: Findings from the 2015 national non-communicable diseases STEPS survey. Ethiop J Health Dev 2017; 31: 313–319. [Google Scholar]
  • 44.Soboka M, Tesfaye M, Feyissa GT, et al. Alcohol use disorders and associated factors among people living with HIV who are attending services in south west Ethiopia. BMC Res Notes 2014; 7: 828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lasebikan VO, Ola BA. Prevalence and correlates of alcohol use among a sample of Nigerian semirural community dwellers in Nigeria. J Addict 2016; 2016: 2831594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rane A, Nadkarni A, Kanekar J, et al. Alcohol use in schizophrenia: prevalence, patterns, correlates and clinical outcomes in Goa, India. Psychiatrist 2012; 36(7): 257–262. [Google Scholar]
  • 47.Reisdorfer E, Büchele F, Pires RO, et al. Prevalence and associated factors with alcohol use disorders among adults: a population-based study in Southern Brazil. Rev Bras Epidemiol 2012; 15(3): 582–594. [DOI] [PubMed] [Google Scholar]
  • 48.Jones RM, Lichtenstein P, Grann M, et al. Alcohol use disorders in schizophrenia: a national cohort study of 12,653 patients. J Clin Psychiatry 2011; 72(6): 775–779; quiz 878. [DOI] [PubMed] [Google Scholar]
  • 49.De Leon J, Diaz FJ, Aguilar MC, et al. Does smoking reduce akathisia? testing a narrow version of the self-medication hypothesis. Schizophr Res 2006; 86(1–3): 256–268. [DOI] [PubMed] [Google Scholar]
  • 50.Mansvelder HD, Van Aerde KI, Couey JJ, et al. Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology 2006; 184(3–4): 292–305. [DOI] [PubMed] [Google Scholar]
  • 51.Segarra R, Zabala A, Eguiluz JI, et al. Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci 2011; 261(4): 241–250. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sj-docx-1-smo-10.1177_20503121211048748 – Supplemental material for Alcohol use disorder and its determinant factors among patients with schizophrenia attending treatment at mental specialized hospital, Addis Ababa, Ethiopia: A cross-sectional study

Supplemental material, sj-docx-1-smo-10.1177_20503121211048748 for Alcohol use disorder and its determinant factors among patients with schizophrenia attending treatment at mental specialized hospital, Addis Ababa, Ethiopia: A cross-sectional study by Habtamu Tadesse, Yohannes Mirkana and Tadesse Misgana in SAGE Open Medicine


Articles from SAGE Open Medicine are provided here courtesy of SAGE Publications

RESOURCES